agilon health, inc. (AGL)

NYSE: AGL · Real-Time Price · USD
92.28
+1.91 (2.11%)
At close: May 29, 2026, 4:00 PM EDT
92.00
-0.28 (-0.30%)
After-hours: May 29, 2026, 7:54 PM EDT
Market Cap1.54B +37.7%
Revenue (ttm)5.82B -2.8%
Net Income-354.54M
EPS-21.38
Shares Out 16.68M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume240,450
Open91.46
Previous Close90.37
Day's Range88.00 - 93.90
52-Week Range7.48 - 94.71
Beta2.30
AnalystsHold
Price Target60.36 (-34.59%)
Earnings DateMay 6, 2026

About AGL

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.

Sector Healthcare
IPO Date Apr 15, 2021
Employees 856
Stock Exchange NYSE
Ticker Symbol AGL
Full Company Profile

Financial Performance

In 2025, agilon health's revenue was $5.93 billion, a decrease of -2.11% compared to the previous year's $6.06 billion. Losses were -$391.35 million, 50.4% more than in 2024.

Financial Statements

Analyst Summary

According to 17 analysts, the average rating for AGL stock is "Hold." The 12-month stock price target is $60.36, which is a decrease of -34.59% from the latest price.

Price Target
$60.36
(-34.59% downside)
Analyst Consensus: Hold
Stock Forecasts

News

Agilon Health upgraded to Equal Weight from Underweight at Barclays

Barclays analyst Andrew Mok upgraded Agilon Health (AGL) to Equal Weight from Underweight with an $81 price target The firm says the outlook for value-based care has “materially improved in…

3 days ago - TheFly

Agilon Health price target raised to $95 from $13 at Benchmark

Benchmark analyst Bill Sutherland raised the firm’s price target on Agilon Health (AGL) to $95 from $13 and keeps a Buy rating on the shares. Following “remarkable” year-to-date performance, the…

8 days ago - TheFly

Agilon Health price target raised to $80 from $18.75 at Citi

Citi raised the firm’s price target on Agilon Health (AGL) to $80 from $18.75 and keeps a Neutral rating on the shares.

14 days ago - TheFly

Agilon Health price target raised to $55 from $17 at TD Cowen

TD Cowen raised the firm’s price target on Agilon Health (AGL) to $55 from $17 and keeps a Hold rating on the shares.The firm updated its model following better than…

18 days ago - TheFly

Agilon Health price target raised to $72 from $37.50 at Wells Fargo

Wells Fargo raised the firm’s price target on Agilon Health (AGL) to $72 from $37.50 and keeps an Overweight rating on the shares. The firm is encouraged by Q1 results…

21 days ago - TheFly

Agilon Health price target raised to $22 from $6.25 at BofA

BofA analyst Craig Jones raised the firm’s price target on Agilon Health (AGL) to $22 from $6.25 and keeps an Underperform rating on the shares. The firm revised estimates to…

22 days ago - TheFly

Agilon Health Is Up 115% After Earnings. Why the Stock Is Having Its Best Day Ever.

Shares of Agilon Health cratered in 2025, driven by financial underperformance and a guidance suspension.

22 days ago - Barrons

Agilon Health price target raised to $35 from $20 at Baird

Baird raised the firm’s price target on Agilon Health (AGL) to $35 from $20 and keeps a Neutral rating on the shares. The firm updated its model following strong Q1…

22 days ago - TheFly

Agilon Health price target raised to $32 from $16 at Evercore ISI

Evercore ISI raised the firm’s price target on Agilon Health (AGL) to $32 from $16 and keeps an In Line rating on the shares.

22 days ago - TheFly

Agilon Health upgraded to Buy from Hold at Deutsche Bank

Deutsche Bank upgraded Agilon Health (AGL) to Buy from Hold with a price target of $49, up from $33. The firm cites the improving macro environment and “compelling” share valuation…

22 days ago - TheFly

Agilon Health upgraded to Buy from Hold at Jefferies

Jefferies analyst Jack Slevin upgraded Agilon Health (AGL) to Buy from Hold with a price target of $48, up from $27.50. The company’s “strong” Q1 results and “clear signs” of…

22 days ago - TheFly

Agilon Health reports Q1 EPS $1.80, consensus 93c

Reports Q1 revenue $1.42B, consensus $1.38B. “Our strong first-quarter performance and increase in full-year 2026 guidance reflects disciplined execution and progress against our strategic priorities....

23 days ago - TheFly

Agilon Health sees FY26 revenue $5.68B-$5.81B, consensus $5.45B

Sees FY26 total members 525K-540K.

23 days ago - TheFly

agilon health Earnings Call Transcript: Q1 2026

First quarter results exceeded expectations, driven by operational discipline, improved data, and AI integration. Full-year 2026 guidance was raised, with strong clinical program expansion and continued focus on cost management and payer contracting.

23 days ago - Transcripts

agilon health Earnings release: Q1 2026

agilon health released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.

23 days ago - Filings

agilon health Quarterly report: Q1 2026

agilon health has published its Q1 2026 quarterly earnings report on May 6, 2026.

23 days ago - Filings

agilon health Reports First Quarter 2026 Results

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the first quarte...

23 days ago - Business Wire

Agilon Health downgraded to Underweight from Neutral at JPMorgan

JPMorgan downgraded Agilon Health (AGL) to Underweight from Neutral with an unchanged price target of $21. The firm believes it will take several quarters for investors to confidently underwrite a…

25 days ago - TheFly

Agilon Health names Tim O’Rourke as new CEO

agilon health (AGL) “announced the appointment of Tim O’Rourke as Chief Executive Officer and a member of the Company’s Board of Directors, effective May 7. He succeeds Ronald A. Williams,…

4 weeks ago - TheFly

agilon health Appoints Tim O'Rourke as Chief Executive Officer

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health (NYSE: AGL) (the “Company”), the trusted partner empowering physicians to transform health care in our communities, today announced the appointment of...

4 weeks ago - Business Wire

agilon health Proxy statement: Proxy filing

agilon health filed a proxy statement on April 27, 2026, providing details for shareholder voting and corporate governance matters.

4 weeks ago - Filings

agilon health Proxy statement: Proxy filing

agilon health filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.

5 weeks ago - Filings

agilon health Proxy statement: Proxy filing

agilon health filed a proxy statement on April 22, 2026, providing details for shareholder voting and corporate governance matters.

5 weeks ago - Filings

Agilon Health price target raised to $17 from 60c at TD Cowen

TD Cowen raised the firm’s price target on Agilon Health (AGL) to $17 from 60c and keeps a Hold rating on the shares. The firm updated its model to reflect…

6 weeks ago - TheFly

Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

7 weeks ago - PRNewsWire